BETAMETHASONE IMPURITY B
Psoriasis
AmgenSmall moleculePhase 3Dormant
B
62/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 89/ 100
Competitive context
9 Active assets in the Psoriasis cohort.
View all 30 →
Same molecule, other indications
BETAMETHASONE IMPURITY B is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →